John Cumbers, George Church, Eric Schmidt John Cumbers, CEO of SynBioBeta, George Church, Geneticist at MIT, and Eric Schmidt, Former Google CEO, discuss the intersection of synthetic biology and digital technology at SynBioBeta 2019.
Home » Featured Slider » Video: Former Google CEO Eric Schmidt Talks Synthetic Biology at SynBioBeta 2019

Video: Former Google CEO Eric Schmidt Talks Synthetic Biology at SynBioBeta 2019

I recently interviewed two titans of technology, each from different worlds. Both have been listed among the 100 most influential people by Time.

Eric Schmidt was CEO of Google from 2001 to 2011, the decade the internet exploded. He also served as chairman of the board and later executive chairman of Alphabet, Google’s parent company. He remains a technical advisor to Alphabet, and serves on the board of both the Broad Institute and the Mayo Clinic. He’s also a science-focused philanthropist.

George Church is a geneticist at MIT. Having helped develop both the gene-editing tool CRISPR and the first method for sequencing a genome, his work has largely defined 21st-century biology. His current projects include growing human organs for transplant and resurrecting the woolly mammoth.

Our wide-ranging conversation centered on the intersection of synthetic biology and digital technology.

Watch the full-length video:

0
John Cumbers

John Cumbers

John Cumbers is the founder of SynBioBeta. John is passionate about education and on the use and adoption of biological technologies. He has received multiple awards and grants from NASA and the National Academy of Sciences for his work in the field. John has been involved in multiple startups such as those producing food for space, microbes to extract lunar and martian resources, and hoverboards! John is an active investor through the DCVC SynBioBeta Fund and his synthetic biology syndicate on AngelList.

Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.

Editor’s picks